0001140361-23-050019.txt : 20231027
0001140361-23-050019.hdr.sgml : 20231027
20231027195600
ACCESSION NUMBER: 0001140361-23-050019
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231027
FILED AS OF DATE: 20231027
DATE AS OF CHANGE: 20231027
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GNI Hong Kong Ltd
CENTRAL INDEX KEY: 0001958509
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51173
FILM NUMBER: 231356941
BUSINESS ADDRESS:
STREET 1: 12/F ELITE CENTRE
STREET 2: 22 HUNG TO ROAD
CITY: KWUN TONG KL
STATE: K3
ZIP: 0000
BUSINESS PHONE: 81-3-6214-3600
MAIL ADDRESS:
STREET 1: 12/F ELITE CENTRE
STREET 2: 22 HUNG TO ROAD
CITY: KWUN TONG KL
STATE: K3
ZIP: 0000
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATALYST BIOSCIENCES, INC.
CENTRAL INDEX KEY: 0001124105
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 562020050
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 611 GATEWAY BLVD., SUITE 710
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-871-0761
MAIL ADDRESS:
STREET 1: 611 GATEWAY BLVD., SUITE 710
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: TARGACEPT INC
DATE OF NAME CHANGE: 20000919
4
1
form4.xml
X0508
4
2023-10-27
true
0001124105
CATALYST BIOSCIENCES, INC.
CBIO
0001958509
GNI Hong Kong Ltd
12/F ELITE CENTRE
22 HUNG TO ROAD
KWUN TONG KL
K3
HONG KONG
true
false
Common Stock
2023-10-27
4
J
0
5371304
D
0
D
Series X Convertible Preferred Stock
2023-10-27
4
J
0
10577
D
Common Stock
105770000
0
D
Represents an internal transfer by the Reporting Person, a wholly-owned indirect subsidiary of GNI Group Ltd., a company incorporated under the laws of Japan with limited liability ("GNI Japan"), to GNI Japan, pursuant to the Share Purchase Agreement, dated as of October 27, 2023, by and between the Reporting Person and GNI Japan, in exchange for consideration of $46,624,376.
Shares of Series X Convertible Preferred Stock of the Issuer, par value $0.001 per share (the "Preferred Stock"), are convertible into shares of common stock of the Issuer at any time at the option of the holder thereof, based on the Conversion Ratio and subject to certain limitations, including the Beneficial Ownership Limitation (as such terms are defined in the Certificate of Designation for the Preferred Stock filed with the Securities and Exchange Commission as Exhibit 3.1 to the Issuer's Form 8-K filed on December 27, 2022).
/s/ Branden Berns, as attorney-in-fact for GNI Hong Kong Ltd
2023-10-27